The microbiota is increasingly recognized as a critical player in cancer onset and
progression and response to cancer chemotherapy treatment. In recent years, several …

The gut microbiota (GM) is considered to constitute a powerful “organ” capable of
influencing the majority of the metabolic, nutritional, physiological, and immunological …

The correlations between microbiota dysbiosis and cancer have gained extensive attention
and been widely explored. As a leading cancer diagnosis worldwide, lung cancer poses a …

The influence of microbiota on host health and disease has attracted adequate attention,
and gut microbiota components and microbiota-derived metabolites affect host immune …

Lung cancer is the top reason for cancer-related deaths worldwide. The 5-year overall
survival rate of lung cancer is approximately 20% due to the delayed diagnosis and low …

Until recently, bacteria have been studied in terms of their roles in infectious diseases and
mainly by using isolation and culture methods. However, in practice, many bacteria existing …

Recent research on cancer-associated microbial communities has elucidated the interplay
between bacteria, immune cells, and tumor cells; the bacterial pathways involved in the …

Like other body districts, lungs present a complex bacteria community. An emerging function
of lung microbiota is to promote and maintain a state of immune tolerance, to prevent …

Lung cancer is one of the deadliest and most common malignancies in the world,
representing one of the greatest challenges in cancer treatment. Immunotherapy is rapidly …

Lung cancer is still the leading cause of cancer death worldwide. Despite the major
diagnostic and therapeutic innovations, the effect on mortality has been modest and the …